• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Anti-Inducible Costimulator Monoclonal Antibody Treatment of Canine Chronic Graft-versus-Host Disease.抗诱导共刺激分子单克隆抗体治疗犬慢性移植物抗宿主病。
Biol Blood Marrow Transplant. 2018 Jan;24(1):50-54. doi: 10.1016/j.bbmt.2017.09.010. Epub 2017 Sep 25.
2
Inducible costimulator (ICOS) up-regulation on activated T cells in chronic graft-versus-host disease after dog leukocyte antigen-nonidentical hematopoietic cell transplantation: a potential therapeutic target.在犬白细胞抗原非匹配造血细胞移植后慢性移植物抗宿主病中活化 T 细胞上诱导共刺激分子(ICOS)的上调:一个潜在的治疗靶点。
Transplantation. 2013 Jul 15;96(1):34-41. doi: 10.1097/TP.0b013e318295c025.
3
Anti-ICOS mAb Targets Pathogenic IL-17A-expressing Cells in Canine Model of Chronic GVHD.抗 ICOS mAb 靶向慢性移植物抗宿主病犬模型中致病性表达 IL-17A 的细胞。
Transplantation. 2021 May 1;105(5):1008-1016. doi: 10.1097/TP.0000000000003489.
4
Targeting of inducible costimulator (ICOS) expressed on alloreactive T cells down-regulates graft-versus-host disease (GVHD) and facilitates engraftment of allogeneic bone marrow (BM).靶向同种异体反应性T细胞上表达的诱导性共刺激分子(ICOS)可下调移植物抗宿主病(GVHD)并促进异基因骨髓(BM)的植入。
Blood. 2005 Apr 15;105(8):3372-80. doi: 10.1182/blood-2004-10-3869. Epub 2004 Dec 23.
5
A Canine Model of Chronic Graft-versus-Host Disease.慢性移植物抗宿主病的犬类模型
Biol Blood Marrow Transplant. 2017 Mar;23(3):420-427. doi: 10.1016/j.bbmt.2016.12.629. Epub 2016 Dec 21.
6
Inducible Costimulator Gene-Transduced Bone Marrow-Derived Mesenchymal Stem Cells Attenuate the Severity of Acute Graft-Versus-Host Disease in Mouse Models.可诱导共刺激分子基因转导的骨髓间充质干细胞减轻小鼠模型中急性移植物抗宿主病的严重程度。
Cell Transplant. 2015;24(9):1717-31. doi: 10.3727/096368914X684592. Epub 2014 Sep 8.
7
JTA-009, a fully human antibody against human AILIM/ICOS, ameliorates graft-vs-host reaction in SCID mice grafted with human PBMCs.JTA-009是一种针对人AILIM/ICOS的全人源抗体,可改善移植了人外周血单核细胞的重症联合免疫缺陷(SCID)小鼠的移植物抗宿主反应。
Exp Hematol. 2008 Nov;36(11):1514-23. doi: 10.1016/j.exphem.2008.06.004. Epub 2008 Aug 19.
8
Absence of inducible costimulator on alloreactive T cells reduces graft versus host disease and induces Th2 deviation.同种异体反应性T细胞上缺乏可诱导共刺激分子可减少移植物抗宿主病并诱导Th2偏移。
Blood. 2005 Nov 1;106(9):3285-92. doi: 10.1182/blood-2005-01-0410. Epub 2005 Jun 14.
9
ICOS immunoPET enables visualization of activated T cells and early diagnosis of murine acute gastrointestinal GvHD.ICOS 免疫 PET 能够可视化活化的 T 细胞,并早期诊断小鼠急性胃肠道移植物抗宿主病。
Blood Adv. 2022 Aug 23;6(16):4782-4792. doi: 10.1182/bloodadvances.2022007403.
10
Opposing effects of anti-activation-inducible lymphocyte-immunomodulatory molecule/inducible costimulator antibody on the development of acute versus chronic graft-versus-host disease.抗激活诱导淋巴细胞免疫调节分子/诱导性共刺激分子抗体对急性与慢性移植物抗宿主病发展的相反作用
J Immunol. 2001 Nov 15;167(10):5741-8. doi: 10.4049/jimmunol.167.10.5741.

引用本文的文献

1
Canine Hematopoietic Cell Transplantation for Graft-Versus-Host Disease.犬造血细胞移植治疗移植物抗宿主病
Methods Mol Biol. 2025;2907:207-236. doi: 10.1007/978-1-0716-4430-0_10.
2
Chronic GvHD NIH Consensus Project Biology Task Force: evolving path to personalized treatment of chronic GvHD.慢性移植物抗宿主病 NIH 共识项目生物学工作组:向慢性移植物抗宿主病个体化治疗的演进之路。
Blood Adv. 2023 Sep 12;7(17):4886-4902. doi: 10.1182/bloodadvances.2022007611.
3
Genotyping of canine MHC gene DLA-88 by next-generation sequencing reveals high frequencies of new allele discovery and gene duplication.基于下一代测序技术的犬 MHC 基因 DLA-88 基因型分析揭示了新等位基因发现和基因重复的高频率。
HLA. 2022 Nov;100(5):479-490. doi: 10.1111/tan.14752. Epub 2022 Aug 9.
4
Evolution of haematopoietic cell transplantation for canine blood disorders and a platform for solid organ transplantation.用于犬血液疾病的造血细胞移植的发展和实体器官移植的平台。
Vet Med Sci. 2021 Nov;7(6):2156-2171. doi: 10.1002/vms3.601. Epub 2021 Aug 14.
5
Developments and translational relevance for the canine haematopoietic cell transplantation preclinical model.犬造血细胞移植临床前模型的发展及转化相关性研究。
Vet Comp Oncol. 2020 Dec;18(4):471-483. doi: 10.1111/vco.12608. Epub 2020 May 26.
6
Animal Models for Preclinical Development of Allogeneic Hematopoietic Cell Transplantation.异基因造血细胞移植临床前开发的动物模型
ILAR J. 2018 Dec 31;59(3):263-275. doi: 10.1093/ilar/ily006.

本文引用的文献

1
A Canine Model of Chronic Graft-versus-Host Disease.慢性移植物抗宿主病的犬类模型
Biol Blood Marrow Transplant. 2017 Mar;23(3):420-427. doi: 10.1016/j.bbmt.2016.12.629. Epub 2016 Dec 21.
2
Inducible costimulator (ICOS) up-regulation on activated T cells in chronic graft-versus-host disease after dog leukocyte antigen-nonidentical hematopoietic cell transplantation: a potential therapeutic target.在犬白细胞抗原非匹配造血细胞移植后慢性移植物抗宿主病中活化 T 细胞上诱导共刺激分子(ICOS)的上调:一个潜在的治疗靶点。
Transplantation. 2013 Jul 15;96(1):34-41. doi: 10.1097/TP.0b013e318295c025.
3
Contribution of B7RP-1/ICOS co-stimulation to lethal acute GVHD.B7RP-1/ICOS共刺激对致死性急性移植物抗宿主病的作用
Pediatr Transplant. 2010 Jun;14(4):540-8. doi: 10.1111/j.1399-3046.2009.01279.x. Epub 2010 Feb 1.
4
Only therapeutic ICOS:ICOSL blockade alleviates acute graft versus host disease.仅治疗性ICOS:ICOSL阻断可减轻急性移植物抗宿主病。
Klin Padiatr. 2009 Nov-Dec;221(6):344-50. doi: 10.1055/s-0029-1239532. Epub 2009 Nov 4.
5
Anti-CTLA-4 treatment induces IL-10-producing ICOS+ regulatory T cells displaying IDO-dependent anti-inflammatory properties in a mouse model of colitis.在结肠炎小鼠模型中,抗CTLA-4治疗可诱导产生白细胞介素-10的ICOS+调节性T细胞,这些细胞表现出吲哚胺2,3-双加氧酶依赖性抗炎特性。
Gut. 2009 Oct;58(10):1363-73. doi: 10.1136/gut.2008.162842. Epub 2009 Jun 7.
6
JTA-009, a fully human antibody against human AILIM/ICOS, ameliorates graft-vs-host reaction in SCID mice grafted with human PBMCs.JTA-009是一种针对人AILIM/ICOS的全人源抗体,可改善移植了人外周血单核细胞的重症联合免疫缺陷(SCID)小鼠的移植物抗宿主反应。
Exp Hematol. 2008 Nov;36(11):1514-23. doi: 10.1016/j.exphem.2008.06.004. Epub 2008 Aug 19.
7
Intensified postgrafting immunosuppression failed to assure long-term engraftment of dog leukocyte antigen-identical canine marrow grafts after 1 gray total body irradiation.在进行1格雷全身照射后,强化的移植后免疫抑制未能确保犬白细胞抗原匹配的犬骨髓移植长期植入。
Transplantation. 2008 Apr 15;85(7):1023-9. doi: 10.1097/TP.0b013e318169be24.
8
ICOS-Dependent and -independent functions of memory CD4 T cells in allograft rejection.记忆性CD4 T细胞在同种异体移植排斥反应中依赖ICOS和不依赖ICOS的功能。
Am J Transplant. 2008 Mar;8(3):497-506. doi: 10.1111/j.1600-6143.2007.02096.x.
9
Stable trichimerism after marrow grafting from 2 DLA-identical canine donors and nonmyeloablative conditioning.来自2个DLA相同犬类供体的骨髓移植及非清髓性预处理后的稳定三嵌合体状态。
Blood. 2007 Jul 1;110(1):418-23. doi: 10.1182/blood-2007-02-071282. Epub 2007 Mar 16.
10
Expression level of costimulatory receptor ICOS is critical for determining the polarization of helper T cell function.共刺激受体ICOS的表达水平对于确定辅助性T细胞功能的极化至关重要。
Transpl Immunol. 2006 Apr;15(4):255-63. doi: 10.1016/j.trim.2006.01.002. Epub 2006 Feb 14.

抗诱导共刺激分子单克隆抗体治疗犬慢性移植物抗宿主病。

Anti-Inducible Costimulator Monoclonal Antibody Treatment of Canine Chronic Graft-versus-Host Disease.

机构信息

Transplantation Biology Program, Fred Hutchinson Cancer Research Center, Seattle, Washington.

Transplantation Biology Program, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Pathology, University of Washington School of Medicine, Seattle, Washington.

出版信息

Biol Blood Marrow Transplant. 2018 Jan;24(1):50-54. doi: 10.1016/j.bbmt.2017.09.010. Epub 2017 Sep 25.

DOI:10.1016/j.bbmt.2017.09.010
PMID:28958896
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5743626/
Abstract

In murine model systems inducible costimulator (ICOS) signaling has been implicated in the formation of chronic graft-versus-host disease (GVHD). Previously, we showed that chronic GVHD can be reproducibly produced in the dog hematopoietic cell transplantation (HCT) model and that ICOS expression is upregulated on T cells in dogs with chronic GVHD. The goal of the present study was to determine whether administration of a short course of anti-canine ICOS mAb could alter the rapid and progressive course of chronic GVHD. Five dogs underwent HCT from dog leukocyte antigen mismatched unrelated donors after total body irradiation. Postgrafting immunosuppression consisted of methotrexate (days 1, 3, 6, and 11) and cyclosporine (days -1 through 78). Anti-ICOS mAb (3 injections, 72 hours apart) was administered upon diagnosis of GVHD. One dog failed to respond to anti-ICOS mAb therapy and succumbed to chronic GVHD in a time course similar to control untreated dogs. Overall, anti-ICOS-treated dogs experienced a significant prolongation in survival from the time of diagnosis of chronic GVHD compared with control dogs. Within the limitations of the number of study dogs we suggest that a short course of anti-ICOS mAb may be useful in the treatment of chronic canine GVHD.

摘要

在诱导共刺激因子(ICOS)信号的鼠模型系统中,已涉及慢性移植物抗宿主病(GVHD)的形成。此前,我们表明,慢性 GVHD 可在犬造血细胞移植(HCT)模型中可重复产生,并且在患有慢性 GVHD 的犬中,ICOS 表达在 T 细胞上上调。本研究的目的是确定短期给予抗犬 ICOS mAb 是否可以改变慢性 GVHD 的快速和进行性病程。5 只犬在全身照射后接受来自犬白细胞抗原不合的无关供体的 HCT。移植后免疫抑制包括甲氨蝶呤(第 1、3、6 和 11 天)和环孢素(第-1 天至第 78 天)。在诊断 GVHD 时给予抗 ICOS mAb(3 次注射,间隔 72 小时)。一只犬对抗 ICOS mAb 治疗无反应,并以类似于对照未治疗犬的时间进程死于慢性 GVHD。总体而言,与对照犬相比,接受抗 ICOS 治疗的犬从慢性 GVHD 诊断开始的生存时间显著延长。在研究犬数量的限制内,我们建议短期给予抗 ICOS mAb 可能对治疗慢性犬 GVHD 有用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e924/5743626/ff3620b35cf7/nihms908519f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e924/5743626/47b0c9c00e19/nihms908519f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e924/5743626/fd5af534c392/nihms908519f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e924/5743626/0105a485d30a/nihms908519f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e924/5743626/ff3620b35cf7/nihms908519f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e924/5743626/47b0c9c00e19/nihms908519f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e924/5743626/fd5af534c392/nihms908519f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e924/5743626/0105a485d30a/nihms908519f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e924/5743626/ff3620b35cf7/nihms908519f4.jpg